KITLG and Thrombocytopenia: Thrombocytopenia is particularly evident when 5FU is combined with other chemotherapeutic drugs, suggesting that interactions between c-kit and endogenously produced SCF are important for megakaryocyte survival in myelosuppressive conditions.